rituximab,doxorubicin,prednisone,vincristine
not tagged
['lymsm']
 -s0016 long term follow up
-chop-r vs chop-rit in fl
-no os benefit- 15y pfs 40% and os 70% seem lower than other studies in fl. #lymsm 
Clinician-researcher-educator @MSKCancerCenter Tweets about #Lymphoma #CLL #GeriOnc #PRO #MedEd Proud alum @OfficialJipmer @AIIMS_ND @UpstateNews @RoswellPark